ARGATRA

Pharmaceutical products for use as an anticoagulant and for the treatment of heparin-induced thrombocytopenia with or without thrombosis, acute coronary syndromes, ischemic stroke, percutaneous coronary interventions, venous thrombosis, arterial thrombosis, coagulopathies, pulmonary embolism, peripheral embolism and hemodialysis